Cargando…

Natural products: potential drugs for the treatment of renal fibrosis

With the increasing prevalence and mortality, chronic kidney disease (CKD) has become a world public health problem. As the primary pathological manifestation in CKD, renal fibrosis is often used as a critical target for the treatment of CKD and inhibits the progression of CKD to end-stage renal dis...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Zijun, Qiao, Yanheng, Zhao, Yanru, Chen, Xin, Li, Jie, Zhang, Hanqing, Lan, Qiumei, Yang, Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9386947/
https://www.ncbi.nlm.nih.gov/pubmed/35978370
http://dx.doi.org/10.1186/s13020-022-00646-z
_version_ 1784769921932066816
author Zhou, Zijun
Qiao, Yanheng
Zhao, Yanru
Chen, Xin
Li, Jie
Zhang, Hanqing
Lan, Qiumei
Yang, Bo
author_facet Zhou, Zijun
Qiao, Yanheng
Zhao, Yanru
Chen, Xin
Li, Jie
Zhang, Hanqing
Lan, Qiumei
Yang, Bo
author_sort Zhou, Zijun
collection PubMed
description With the increasing prevalence and mortality, chronic kidney disease (CKD) has become a world public health problem. As the primary pathological manifestation in CKD, renal fibrosis is often used as a critical target for the treatment of CKD and inhibits the progression of CKD to end-stage renal disease (ESRD). As a potential drug, natural products have been confirmed to have the potential as a routine or supplementary therapy for chronic kidney disease, which may target renal fibrosis and act through various pharmacological activities such as anti-inflammatory and anti-oxidation of natural products. This article briefly introduces the pathological mechanism of renal fibrosis and systematically summarizes the latest research on the treatment of renal fibrosis with natural products of Chinese herbal medicines.
format Online
Article
Text
id pubmed-9386947
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-93869472022-08-19 Natural products: potential drugs for the treatment of renal fibrosis Zhou, Zijun Qiao, Yanheng Zhao, Yanru Chen, Xin Li, Jie Zhang, Hanqing Lan, Qiumei Yang, Bo Chin Med Review With the increasing prevalence and mortality, chronic kidney disease (CKD) has become a world public health problem. As the primary pathological manifestation in CKD, renal fibrosis is often used as a critical target for the treatment of CKD and inhibits the progression of CKD to end-stage renal disease (ESRD). As a potential drug, natural products have been confirmed to have the potential as a routine or supplementary therapy for chronic kidney disease, which may target renal fibrosis and act through various pharmacological activities such as anti-inflammatory and anti-oxidation of natural products. This article briefly introduces the pathological mechanism of renal fibrosis and systematically summarizes the latest research on the treatment of renal fibrosis with natural products of Chinese herbal medicines. BioMed Central 2022-08-17 /pmc/articles/PMC9386947/ /pubmed/35978370 http://dx.doi.org/10.1186/s13020-022-00646-z Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Review
Zhou, Zijun
Qiao, Yanheng
Zhao, Yanru
Chen, Xin
Li, Jie
Zhang, Hanqing
Lan, Qiumei
Yang, Bo
Natural products: potential drugs for the treatment of renal fibrosis
title Natural products: potential drugs for the treatment of renal fibrosis
title_full Natural products: potential drugs for the treatment of renal fibrosis
title_fullStr Natural products: potential drugs for the treatment of renal fibrosis
title_full_unstemmed Natural products: potential drugs for the treatment of renal fibrosis
title_short Natural products: potential drugs for the treatment of renal fibrosis
title_sort natural products: potential drugs for the treatment of renal fibrosis
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9386947/
https://www.ncbi.nlm.nih.gov/pubmed/35978370
http://dx.doi.org/10.1186/s13020-022-00646-z
work_keys_str_mv AT zhouzijun naturalproductspotentialdrugsforthetreatmentofrenalfibrosis
AT qiaoyanheng naturalproductspotentialdrugsforthetreatmentofrenalfibrosis
AT zhaoyanru naturalproductspotentialdrugsforthetreatmentofrenalfibrosis
AT chenxin naturalproductspotentialdrugsforthetreatmentofrenalfibrosis
AT lijie naturalproductspotentialdrugsforthetreatmentofrenalfibrosis
AT zhanghanqing naturalproductspotentialdrugsforthetreatmentofrenalfibrosis
AT lanqiumei naturalproductspotentialdrugsforthetreatmentofrenalfibrosis
AT yangbo naturalproductspotentialdrugsforthetreatmentofrenalfibrosis